Cerus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cerus and other ETFs, options, and stocks.

About CERS

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. 

CEO
William Mariner Greenman
CEOWilliam Mariner Greenman
Employees
281
Employees281
Headquarters
Concord, California
HeadquartersConcord, California
Founded
1991
Founded1991
Employees
281
Employees281

CERS Key Statistics

Market cap
500.39M
Market cap500.39M
Price-Earnings ratio
-30.70
Price-Earnings ratio-30.70
Dividend yield
Dividend yield
Average volume
2.05M
Average volume2.05M
High today
$2.77
High today$2.77
Low today
$2.58
Low today$2.58
Open price
$2.74
Open price$2.74
Volume
1.83M
Volume1.83M
52 Week high
$2.96
52 Week high$2.96
52 Week low
$1.12
52 Week low$1.12

Stock Snapshot

As of today, Cerus(CERS) shares are valued at $2.61. The company's market cap stands at 500.39M, with a P/E ratio of -30.70.

During the trading session on 2026-01-19, Cerus(CERS) shares reached a daily high of $2.77 and a low of $2.58. At a current price of $2.61, the stock is +1.3% higher than the low and still -5.9% under the high.

Trading volume for Cerus(CERS) stock has reached 1.83M, versus its average volume of 2.05M.

The stock's 52-week range extends from a low of $1.12 to a high of $2.96.

The stock's 52-week range extends from a low of $1.12 to a high of $2.96.

People also own

Based on the portfolios of people who own CERS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .